Implications of 12-Lipoxygenase and NOX-1 in beta-Cell dysfunction, a potential target for Diabetes

$186,552ZIAFY2020TRNIH

National Center For Advancing Translational Sciences

Investigators

Anton Simeonovcontact

Linked publications, trials & patents

Paper 26899595 Paper 25417214 Paper 24684213

View original record on NIH RePORTER →

Implications of 12-Lipoxygenase and NOX-1 in beta-Cell dysfunction, a potential target for Diabetes · GrantIndex